DL
Therapeutic Areas
Protagenic Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PT00114 | Stress-related Neuropsychiatric Disorders (e.g., Depression, Anxiety, PTSD, Addiction) | Phase 1 |
| TCAP Platform | Neurodegenerative Diseases (e.g., Alzheimer's, Parkinson's) | Preclinical |